Neo Ivy Capital Management initiated a new position in American Healthcare REIT by purchasing 136,925 shares worth approximately $6.44 million. The REIT delivered strong 16.4% same-store NOI growth in Q3, driven by senior housing and integrated senior health campuses segments. Shares have surged 93% over the past year, with management raising full-year guidance.

S&P Dow Jones Indices announced index changes effective January 30 and February 2, 2026. TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT will be promoted to the S&P MidCap 400, while Amneal Pharmaceuticals, Apellis Pharmaceuticals, and LegalZoom.com will join the S&P SmallCap 600. These changes follow several pending M&A transactions and corporate actions.

Land & Buildings Investment Management sold its entire $18.3 million stake in Kite Realty Group Trust, signaling potential challenges in the retail real estate investment trust (REIT) sector amid rising interest rates and changing consumer habits.

Land & Buildings Investment Management sold its entire $20 million stake in Rexford Industrial Realty, signaling potential challenges in the REIT market amid high interest rates and slower transaction activity.

American Healthcare REIT, Inc. (AHR) announced a quarterly distribution of $0.25 per share for the first quarter of 2025, payable on April 17, 2025 to shareholders of record as of March 31, 2025.

American Healthcare REIT, Inc. (AHR) announced a quarterly distribution of $0.25 per share for the quarter ending December 31, 2024, payable on January 17, 2025. The company is a self-managed real estate investment trust that acquires, owns, and operates a diversified portfolio of clinical healthcare real estate properties.

Investors need to pay close attention to American Healthcare (AHR) stock based on the movements in the options market lately.

American Healthcares (NYSE:AHR) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 7 1 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 1 0 0 0 3M Ago 1 5 1 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $16.18, along with a high estimate of $18.00 and a low estimate of $14.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 4.82%. Exploring Analyst Ratings: An In-Depth Overview A comprehensive examination of how financial experts perceive American Healthcares is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Aaron Hecht JMP Securities Maintains Market Outperform $16.00 - Michael Lewis Truist Securities Lowers Buy $16.00 $17.00 Michael Lewis Truist Securities Maintains Buy $17.00 - Aaron Hecht JMP Securities Maintains Market Outperform $16.00 - Anthony Powell Barclays Announces Overweight $18.00 - Brian Cheng RBC Capital Announces Outperform $15.00 - Aaron Hecht JMP Securities Announces Market Outperform $16.00 - Michael Lewis Truist Securities Announces Buy $17.00 - Ronald Kamdem Morgan Stanley Announces Overweight $17.00 - Michael Griffin Citigroup Announces Neutral $14.00 - Austin Wurschmidt Keybanc Announces Overweight $16.00 - Key Insights: Action Taken: Responding to ...Full story available on Benzinga.com

American Healthcare (AHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Throughout the last three months, 10 analysts have evaluated American Healthcares (NYSE:AHR), offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 6 1 0 0 Last 30D 1 0 0 0 0 1M Ago 2 6 1 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 Analysts have set 12-month price targets for American Healthcares, revealing an average target of $16.2, a high estimate of $18.00, and a low estimate of $14.00. This current average has decreased by 4.71% from the previous average price target of $17.00. Understanding Analyst Ratings: A Comprehensive Breakdown The analysis of recent analyst actions sheds light on the perception of American Healthcares by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Michael Lewis Truist Securities Lowers Buy $16.00 $17.00 Michael Lewis Truist Securities Maintains Buy $17.00 - Aaron Hecht JMP Securities Maintains Market Outperform $16.00 - Anthony Powell Barclays Announces Overweight $18.00 - Brian Cheng RBC Capital Announces Outperform $15.00 - Aaron Hecht JMP Securities Announces Market Outperform $16.00 - Michael Lewis Truist Securities Announces Buy $17.00 - Ronald Kamdem Morgan Stanley Announces Overweight $17.00 - Michael Griffin Citigroup Announces Neutral $14.00 - Austin Wurschmidt Keybanc Announces Overweight $16.00 - Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts ...Full story available on Benzinga.com

In February, American Healthcare REIT Inc (NYSE:AHR) completed its initial public offering of 64.4 million shares at $12.00 per share. The company is a self-managed real estate investment trust (REIT) that acquires, owns, and operates a portfolio of clinical healthcare real estate properties, focusing primarily on medical office buildings, senior housing, skilled nursing facilities, hospitals, and other healthcare-related facilities. Truist Securities initiates coverage on American Healthcare REIT with a Buy rating and a price target of $17, which implies a 32% total return.  Truist analysts anticipate strong earnings growth for the project, driven by the post-COVID fundamental recovery and the potential exercise of an option to acquire a greater stake in its leading operator.  Despite the ...Full story available on Benzinga.com

Stay informed of upcoming IPOs, earnings reports, and market events with Seeking Alpha's Stocks to Watch newsletter.